Delivery Order SPE2DB22D2211-SPE2DB25FSFUU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $9,122.50 to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes (3 mL units) on September 23, 2025, with completion targeted for October 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded through open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Gel-One 30 mg/3 mL syringes with a ceiling value of $1,094.70. This is a firm fixed-price delivery order with an ultimate completion date of September 8, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,824.50 to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 mL syringes on July 30, 2025, with an ultimate completion date of August 20, 2025. This competitive contract award, which carries no set-aside designation, is structured as a firm fixed price delivery order. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order valued at $18,245.00 to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 mL syringes on September 22, 2025. The contract is structured as a firm fixed price delivery order with an ultimate completion date of October 14, 2025, and carries no set-aside designation. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This award is issued under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Gel-One 30 mg/3 mL syringes valued at $9,122.50 with completion scheduled for October 7, 2025. This firm fixed-price delivery order, performed at AmerisourceBergen's Conshohocken, Pennsylvania location, was competitively awarded without set-aside designation. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Gel-One 30 mg/3 mL syringes with a ceiling value of $5,473.50. This firm fixed price delivery order, with an ultimate completion date of September 12, 2025, represents a competitive award with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. As a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $5,473.50 to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Gel-One 30 mg/3 ml syringes. This competitive, firm fixed-price delivery order is scheduled for completion by September 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was awarded through open competition. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a $3,649 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Gel-One 30 mg/3 mL syringes. This firm fixed-price delivery order is expected to be completed by August 12, 2025, and represents a non-competitive set-aside contract. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $14,596 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Gel-One 30 mg/3 mL syringes. The contract, which is competitively awarded with no set-aside designation, carries a firm fixed price structure and an ultimate completion date of September 10, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a leading...
- The Defense Logistics Agency (DLA) awarded a $7,298.00 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Gel-One 30 mg/3 mL syringes. This competitively awarded, firm fixed-price contract is classified as a non-set-aside delivery order with performance to be completed by October 9, 2025, at the vendor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSFUUDelivery Order
The Defense Logistics Agency awarded a $21,894.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 mL syringes on September 24, 2025, with an ultimate completion date of October 16, 2025. This non-set-aside award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion and extending through December 2026. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this order as part of its comprehensive role supplying pharmaceutical products and medical devices to federal military and veteran healthcare systems. The company's $1 billion IDC with DLA serves as a global pharmaceutical support vehicle enabling supply of medications, vaccines, syringes, and other medical commodities across multiple therapeutic domains to support military healthcare programs worldwide. This delivery order reflects the company's established capability to meet federal procurement requirements through competitive bidding and its position as a critical vendor within the Defense Health Agency's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.9k | 9/24/25 |